Nitric oxide in the nervous system. Biochemical, developmental, and neurobiological aspects

Vitamins and Hormones

Volumn 96, Issue , 2014, Pages 79-125

  Cossenza, Marcelo ^a   Socodato, Renato ^a   Portugal, Camila C ^a   Domith, Ivan C L ^a   Gladulich, Luis F H ^a   Encarnação, Thaísa G ^a   Calaza, Karin C ^a   Mendonça, Henrique R ^a   Campello Costa, Paula ^a   Paes de Carvalho, Roberto ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cyclic GMP PKG pathway; Neurotransmitters; Retina; S nitrosylation; Synaptic plasticity

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NITRIC OXIDE;

ANIMAL; CENTRAL NERVOUS SYSTEM; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; NEURONAL PLASTICITY; NEURONS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 84906829926     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800254-4.00005-2     Document Type: Chapter

References (253)

1. Alderton W., Cooper C., Knowles R. Nitric oxide synthases: Structure, function and inhibition. The Biochemical Journal 2001, 357:593-615.
2. Allen N.J., Barres B.A. Intercellular communication in the nervous system 2009, Elsevier, (Glia and synapse formation: An overview). 1st ed.
3. Almeida A., Almeida J., Bolanos J.P., Moncada S. Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(26):15294-15299.
4. Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America 1977, 74(8):3203-3207.
5. Ayata C., Ayata G., Hara H., Matthews R.T., Beal M.F., Ferrante R.J., et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. The Journal of Neuroscience 1997, 17(18):6908-6917.
6. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. The Journal of Neuroscience 2001, 21(17):6480-6491.
7. Bal-Price A., Moneer Z., Brown G.C. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 2002, 40(3):312-323.
8. Bartus K., Pigott B., Garthwaite J. Cellular targets of nitric oxide in the hippocampus. PLoS One 2013, 8(2):e57292.
9. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320(5879):1050-1054.
10. Berman S., Morris A. Nitric oxide as a putative retinal axon pathfinding and target recognition cue in Xenopus laevis. Impulse (Columbia) 2011, 2010:1-12.
11. Bian K., Gao Z., Weisbrodt N., Murad F. The nature of heme/iron-induced protein tyrosine nitration. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(10):5712-5717.
12. Bleckert A., Wong R.O. Identifying roles for neurotransmission in circuit assembly: Insights gained from multiple model systems and experimental approaches. Bioessays 2011, 33(1):61-72.
13. Boehning D., Snyder S.H. Novel neural modulators. Annual Review of Neuroscience 2003, 26:105-131.
14. Bogdan C. Nitric oxide and the immune response. Nature Immunology 2001, 2(10):907-916.
15. Bogdanov M.B., Wurtman R.J. Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: An in vivo microdialysis study. Neuroscience Letters 1997, 221(2):197-201.
16. Boran M.S., Garcia A. The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. Journal of Neurochemistry 2007, 102(1):216-230.
17. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351(6329):714-718.
18. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990, 347(6295):768.
19. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(2):682-685.
20. Brenman J.E., Bredt D.S. Synaptic signaling by nitric oxide. Current Opinion in Neurobiology 1997, 7(3):374-378.
21. Brown G.C. Nitric oxide and neuronal death. Nitric Oxide 2010, 23(3):153-165.
22. Bugnon O., Schaad N.C., Schorderet M. Nitric oxide modulates endogenous dopamine release in bovine retina. Neuroreport 1994, 5(4):401-404.
23. Butt E., Geiger J., Jarchau T., Lohmann S.M., Walter U. The cGMP-dependent protein kinase-Gene, protein, and function. Neurochemical Research 1993, 18(1):27-42.
24. Büyükuysal R.L. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate. Fundamental and Clinical Pharmacology 1997, 11(6):528-536.
25. Cabral-Miranda F., Serfaty C.A., Campello-Costa P. A time-dependent effect of caffeine upon lesion-induced plasticity. Neuroscience Research 2011, 71(1):99-102.
26. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circulation Research 2000, 87(10):840-844.
27. Campello-Costa P., Fosse A.M., Ribeiro J.C., Paes-De-Carvalho R., Serfaty C.A. Acute blockade of nitric oxide synthesis induces disorganization and amplifies lesion-induced plasticity in the rat retinotectal projection. Journal of Neurobiology 2000, 44(4):371-381.
28. Campos F., Alfonso M., Vidal L., Faro L.R., Durán R. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study. European Journal of Pharmacology 2006, 548(1-3):90-98.
29. Carlsson A. A half-century of neurotransmitter research: Impact on neurology and psychiatry. Nobel lecture. Bioscience Reports 2001, 21(6):691-710.
30. Chepkova A.N., Fleischer W., Kazmierczak T., Doreulee N., Haas H.L., Sergeeva O.A. Developmental alterations of DHPG-induced long-term depression of corticostriatal synaptic transmission: Switch from NMDA receptor-dependent towards CB1 receptor-dependent plasticity. Pflügers Archiv 2009, 459(1):131-141.
31. Cho H.J., Xie Q., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. The Journal of Experimental Medicine 1992, 176(2):599-604.
32. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120(3):421-433.
33. Chung K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C., Marsh L., et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004, 304(5675):1328-1331.
34. Ciani E., Guidi S., Bartesaghi R., Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide. Journal of Neurochemistry 2002, 82(5):1282-1289.
35. Ciani E., Virgili M., Contestabile A. Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurones. Journal of Neurochemistry 2002, 81(2):218-228.
36. Coesmans M., Weber J.T., De Zeeuw C.I., Hansel C. Bidirectional parallel fiber plasticity in the cerebellum under climbing fiber control. Neuron 2004, 44(4):691-700.
37. Cohen R.A., Weisbrod R.M. Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. The American Journal of Physiology 1988, 254(5 Pt 2):H871-H878.
38. Cohen-Cory S. The developing synapse: Construction and modulation of synaptic structures and circuits. Science 2002, 298(5594):770-776.
39. Collingridge G.L., Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends in Pharmacological Sciences 1990, 11(7):290-296.
40. Contestabile A. Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells. Progress in Neurobiology 2008, 84(4):317-328.
41. Contestabile A. Role of nitric oxide in cerebellar development and function: Focus on granule neurons. Cerebellum 2012, 11(1):50-61.
42. Cooke R.M., Mistry R., Challiss R.A., Straub V.A. Nitric oxide synthesis and cGMP production is important for neurite growth and synapse remodeling after axotomy. The Journal of Neuroscience 2013, 33(13):5626-5637.
43. Cork R.J., Namkung Y., Shin H.S., Mize R.R. Development of the visual pathway is disrupted in mice with a targeted disruption of the calcium channel beta (3)-subunit gene. The Journal of Comparative Neurology 2001, 440(2):177-191.
44. Cossenza M., Cadilhe D.V., Coutinho R.N., Paes-de-Carvalho R. Inhibition of protein synthesis by activation of NMDA receptors in cultured retinal cells: A new mechanism for the regulation of nitric oxide production. Journal of Neurochemistry 2006, 97(5):1481-1493.
45. Cossenza M., Paes de Carvalho R. l-Arginine uptake and release by cultured avian retinal cells: Differential cellular localization in relation to nitric oxide synthase. Journal of Neurochemistry 2000, 74(5):1885-1894.
46. Costa C., Tozzi A., Siliquini S., Galletti F., Cardaioli G., Tantucci M., et al. A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: Modulation by zonisamide. Neurobiology of Disease 2011, 44(2):185-191.
47. Cramer K.S., Sur M. The neuronal form of nitric oxide synthase is required for pattern formation by retinal afferents in the ferret lateral geniculate nucleus. Brain Research. Developmental Brain Research 1999, 116(1):79-86.
48. Cserep C., Szonyi A., Veres J.M., Nemeth B., Szabadits E., de Vente J., et al. Nitric oxide signaling modulates synaptic transmission during early postnatal development. Cerebral Cortex 2011, 21(9):2065-2074.
49. Dachtler J., Hardingham N.R., Glazewski S., Wright N.F., Blain E.J., Fox K. Experience-dependent plasticity acts via GluR1 and a novel neuronal nitric oxide synthase-dependent synaptic mechanism in adult cortex. The Journal of Neuroscience 2011, 31(31):11220-11230.
50. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 2001, 65(1):1-105.
51. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91(2):231-241.
52. Davis S., Laroche S. Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: A review. Genes, Brain and Behavior 2006, 5(Suppl. 2):61-72.
53. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(14):6368-6371.
54. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. The Journal of Neuroscience 1996, 16(8):2479-2487.
55. Deguchi T., Yoshioka M. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. Journal of Biological Chemistry 1982, 257(17):10147-10151.
56. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochimica et Biophysica Acta 1999, 1411(2-3):334-350.
57. de Velasco P.C., Mendonca H.R., Borba J.M., Andrade da Costa B.L., Guedes R.C., Navarro D.M., et al. Nutritional restriction of omega-3 fatty acids alters topographical fine tuning and leads to a delay in the critical period in the rodent visual system. Experimental Neurology 2012, 234(1):220-229.
58. Di Matteo V., Pierucci M., Benigno A., Esposito E., Crescimanno G., Di Giovanni G. Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats. CNS Neuroscience and Therapeutics 2010, 16(3):127-136.
59. Dinerman J.L., Steiner J.P., Dawson T.M., Dawson V., Snyder S.H. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 1994, 33(11):1245-1251.
60. Du J.L., Wei H.P., Wang Z.R., Wong S.T., Poo M.M. Long-range retrograde spread of LTP and LTD from optic tectum to retina. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(45):18890-18896.
61. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275(5300):661-665.
62. Ernst A.F., Gallo G., Letourneau P.C., McLoon S.C. Stabilization of growing retinal axons by the combined signaling of nitric oxide and brain-derived neurotrophic factor. The Journal of Neuroscience 2000, 20(4):1458-1469.
63. Espirito-Santo S., Mendonça H.R., Menezes G.D., Goulart V.G., Gomes A.L., Marra C., et al. Intravitreous interleukin-2 treatment and inflammation modulates glial cells activation and uncrossed retinotectal development. Neuroscience 2012, 200:223-236.
64. Esplugues J.V. NO as a signalling molecule in the nervous system. British Journal of Pharmacology 2002, 135(5):1079-1095.
65. Faro L.R., Ferreira Nunes B.V., Alfonso M., Ferreira V.M., Durán R. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum. Toxicology 2013, 311(3):154-161.
66. Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. Journal of Cell Science 2005, 118(24):5675-5678.
67. Ferrendelli J.A., Chang M.M., Kinscherf D.A. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. Journal of Neurochemistry 1974, 22(4):535-540.
68. Ferriero D.M., Sheldon R.A., Black S.M., Chuai J. Selective destruction of nitric oxide synthase neurons with quisqualate reduces damage after hypoxia-ischemia in the neonatal rat. Pediatric Research 1995, 38(6):912-918.
69. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: Cause or consequence of neurological disorders?. Brain Research. Brain Research Reviews 2002, 39(1):29-54.
70. Finney E.M., Shatz C.J. Establishment of patterned thalamocortical connections does not require nitric oxide synthase. The Journal of Neuroscience 1998, 18(21):8826-8838.
71. Flores A.I., Mallon B.S., Matsui T., Ogawa W., Rosenzweig A., Okamoto T., et al. Akt-mediated survival of oligodendrocytes induced by neuregulins. The Journal of Neuroscience 2000, 20(20):7622-7630.
72. Flores A.I., Narayanan S.P., Morse E.N., Shick H.E., Yin X., Kidd G., et al. Constitutively active Akt induces enhanced myelination in the CNS. The Journal of Neuroscience 2008, 28(28):7174-7183.
73. Friebe A., Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Circulation Research 2003, 93(2):96.
74. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288(5789):373-376.
75. Gallo G., Ernst A.F., McLoon S.C., Letourneau P.C. Transient PKA activity is required for initiation but not maintenance of BDNF-mediated protection from nitric oxide-induced growth-cone collapse. The Journal of Neuroscience 2002, 22(12):5016-5023.
76. Gallo E.F., Iadecola C. Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. The Journal of Neuroscience 2011, 31(19):6947-6955.
77. Garcia-Martinez J., Moran J., Clarke R., Gray A., Cosulich S., Chresta C., et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). The Biochemical Journal 2009, 421:29-42.
78. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. The Journal of Clinical Investigation 1989, 83(5):1774-1777.
79. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends in Neurosciences 1991, 14(2):60-67.
80. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. The European Journal of Neuroscience 2008, 27(11):2783-2802.
81. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988, 336(6197):385-388.
82. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology 1989, 172(4-5):413-416.
83. Getting S.J., Segieth J., Ahmad S., Biggs C.S., Whitton P.S. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Research 1996, 717(1-2):196-199.
84. Godfrey E.W., Schwarte R.C. Nitric oxide and cyclic GMP regulate early events in agrin signaling in skeletal muscle cells. Experimental Cell Research 2010, 316(12):1935-1945.
85. Gould N., Doulias P.T., Tenopoulou M., Raju K., Ischiropoulos H. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. The Journal of Biological Chemistry 2013, 288(37):26473-26479.
86. Greenberg S.S., Diecke F.P., Peevy K., Tanaka T.P. Release of norepinephrine from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor. American Journal of Hypertension 1990, 3(3):211-218.
87. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. Journal of Neurochemistry 1994, 62(2):807-810.
88. Ha K.S., Kim K.M., Kwon Y.G., Bai S.K., Nam W.D., Yoo Y.M., et al. Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. The FASEB Journal 2003, 17(9):1036-1047.
89. Halbrügge T., Lütsch K., Thyen A., Graefe K.H. Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline. Naunyn-Schmiedeberg's Archives of Pharmacology 1991, 344(6):720-727.
90. Halbrügge T., Lütsch K., Thyen A., Graefe K.H. Vasodilatation by endothelium-derived nitric oxide as a major determinant of noradrenaline release. Journal of Neural Transmission, Supplement 1991, 34:113-119.
91. Halmos G., Horváth T., Polony G., Fekete A., Kittel A., van der Vizi E.S., et al. The role of N-methyl-d-aspartate receptors and nitric oxide in cochlear dopamine release. Neuroscience 2008, 154(2):796-803.
92. Hanada M., Feng J., Hemmings B.A. Structure, regulation and function of PKB/AKT-A major therapeutic target. Biochimica et Biophysica Acta 2004, 1697(1):3-16.
93. Hanafy K.A., Krumenacker J.S., Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Medical Science Monitor 2001, 7(4):801-819.
94. Hanania T., Johnson K.M. Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. European Journal of Pharmacology 1998, 359(2-3):111-117.
95. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nature Review Neuroscience 2010, 11(10):682-696.
96. Harris E.W., Ganong A.H., Cotman C.W. Long-term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors. Brain Research 1984, 323(1):132-137.
97. Hattori K., Naguro I., Runchel C., Ichijo H. The roles of ASK family proteins in stress responses and diseases. Cell Communication and Signaling 2009, 7:9.
98. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: Purview and parameters. Nature Reviews Molecular and Cell Biology 2005, 6(2):150-166.
99. Hess D.T., Patterson S.I., Smith D.S., Skene J.H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993, 366(6455):562-565.
100. Hibbs J.B., Vavrin Z., Taintor R.R. l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. The Journal of Immunology 1987, 138(2):550-565.
101. Hirsch D.B., Steiner J.P., Dawson T.M., Mammen A., Hayek E., Snyder S.H. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Current Biology 1993, 3(11):749-754.
102. Hong S.K., Jung I.S., Bang S.A., Kim S.E. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: An in vivo microdialysis study. Neuroscience Letters 2006, 409(3):220-223.
103. Hu W., Zhang M., Czéh B., Flügge G., Zhang W. Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology 2010, 8:1693-1707.
104. Huang C.C., Chan S.H., Hsu K.S. cGMP/protein kinase G-dependent potentiation of glutamatergic transmission induced by nitric oxide in immature rat rostral ventrolateral medulla neurons in vitro. Molecular Pharmacology 2003, 64(2):521-532.
105. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242.
106. Huang Y., Man H.Y., Sekine-Aizawa Y., Han Y., Juluri K., Luo H., et al. S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron 2005, 46(4):533-540.
107. Hull E.M., Dominguez J.M. Getting his act together: Roles of glutamate, nitric oxide, and dopamine in the medial preoptic area. Brain Research 2006, 1126(1):66-75.
108. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. The Journal of Neuroscience 1997, 17(23):9157-9164.
109. 3H]GABA release from chick retina cells. FEBS Letters 1997, 417(3):345-348.
110. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1987, 84(24):9265-9269.
111. Ishide T., Nauli S.M., Maher T.J., Ally A. Cardiovascular responses and neurotransmitter changes following blockade of nNOS within the ventrolateral medulla during static muscle contraction. Brain Research 2003, 977(1):80-89.
112. Jaffrey S.R., Benfenati F., Snowman A.M., Czernik A.J., Snyder S.H. Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(5):3199-3204.
113. Jaffrey S.R., Snowman A.M., Eliasson M.J., Cohen N.A., Snyder S.H. CAPON: A protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 1998, 20(1):115-124.
114. Jaffrey S.R., Snyder S.H. PIN: An associated protein inhibitor of neuronal nitric oxide synthase. Science 1996, 274(5288):774-777.
115. Kaehler S.T., Singewald N., Sinner C., Philippu A. Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Research 1999, 835(2):346-349.
116. 2+ and promotes nicotine-triggered MAPK pathway in PC12 cells. Nitric Oxide 2013, 34:3-9.
117. Kakizawa S., Yamazawa T., Chen Y., Ito A., Murayama T., Oyamada H., et al. Nitric oxide-induced calcium release via ryanodine receptors regulates neuronal function. The EMBO Journal 2012, 31(2):417-428.
118. Kano T., Shimizu-Sasamata M., Huang P., Moskowitz M., Lo E. Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo. Neuroscience 1998, 86(3):695-699.
119. Katsuki S., Arnold W., Mittal C., Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. Journal of Cyclic Nucleotide Research 1977, 3(1):23-35.
120. Kendrick K.M., Guevara-Guzman R., Riva C., Christensen J., Ostergaard K., Emson P.C. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: In vivo evidence that nitric oxide may play a neuroprotective role. The European Journal of Neuroscience 1996, 8(12):2619-2634.
121. Kirchner L., Weitzdoerfer R., Hoeger H., Url A., Schmidt P., Engelmann M., et al. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Nitric Oxide 2004, 11(4):316-330.
122. Kishi T., Hirooka Y., Sakai K., Shigematsu H., Shimokawa H., Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001, 38(4):896-901.
123. Knowles R.G., Palacios M., Palmer R.M., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(13):5159-5162.
124. Koesling D., Russwurm M., Mergia E., Mullershausen F., Friebe A. Nitric oxide-sensitive guanylyl cyclase: Structure and regulation. Neurochemistry International 2004, 45(6):813-819.
125. Kristof A.S., Goldberg P., Laubach V., Hussain S.N. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 1998, 158(6):1883-1889.
126. Krumenacker J.S., Hanafy K.A., Murad F. Regulation of nitric oxide and soluble guanylyl cyclase. Brain Research Bulletin 2004, 62(6):505-515.
127. Kwak Y.D., Ma T., Diao S., Zhang X., Chen Y., Hsu J., et al. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Molecular Neurodegeneration 2010, 5:49.
128. Lamas S., Marsden P.A., Li G.K., Tempst P., Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(14):6348-6352.
129. Lawrence A.J., Jarrott B. Nitric oxide increases interstitial excitatory amino acid release in the rat dorsomedial medulla oblongata. Neuroscience Letters 1993, 151(2):126-129.
130. Lee B., Butcher G.Q., Hoyt K.R., Impey S., Obrietan K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): Kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. The Journal of Neuroscience 2005, 25(5):1137-1148.
131. Lee P.C., Salyapongse A.N., Bragdon G.A., Shears L.L., Watkins S.C., Edington H.D., et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. The American Journal of Physiology 1999, 277(4):H1600-H1608.
132. Lee C.M., Stoelzel C., Chistiakova M., Volgushev M. Heterosynaptic plasticity induced by intracellular tetanization in layer 2/3 pyramidal neurons in rat auditory cortex. The Journal of Physiology 2012, 590(10):2253-2271.
133. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochemical and Biophysical Research Communications 1997, 240(2):419-424.
134. Li D.P., Chen S.R., Finnegan T.F., Pan H.L. Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. The Journal of Physiology 2004, 554(Pt 1):100-110.
135. Li J.Y., Plomann M., Brundin P. Huntington's disease: A synaptopathy?. Trends in Molecular Medicine 2003, 9(10):414-420.
136. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine 1999, 5(12):1403-1409.
137. Lindsay S.L., Ramsey S., Aitchison M., Renne T., Evans T.J. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239. Journal of Cell Science 2007, 120(17):3011-3021.
138. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993, 364(6438):626-632.
139. Liu S., Ninan I., Antonova I., Battaglia F., Trinchese F., Narasanna A., et al. Alpha-Synuclein produces a long-lasting increase in neurotransmitter release. The EMBO Journal 2004, 23(22):4506-4516.
140. Liu D.H., Yuan F.G., Hu S.Q., Diao F., Wu Y.P., Zong Y.Y., et al. Endogenous nitric oxide induces activation of apoptosis signal-regulating kinase 1 via S-nitrosylation in rat hippocampus during cerebral ischemia-reperfusion. Neuroscience 2013, 229:36-48.
141. Lo F.S., Mize R.R. Synaptic regulation of L-type Ca(2+) channel activity and long-term depression during refinement of the retinocollicular pathway in developing rodent superior colliculus. The Journal of Neuroscience 2000, 20(3):RC58.
142. 3H]dopamine release from striatal slices. Journal of Neuroscience Research 1993, 35(2):192-198.
143. Lonart G., Wang J., Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. European Journal of Pharmacology 1992, 220(2):271-272.
144. Lorrain D.S., Hull E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 1993, 5(1):87-89.
145. Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(15):6711-6715.
146. Lu Y.F., Hawkins R.D. Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. Journal of Neurophysiology 2002, 88(3):1270-1278.
147. Lu Y.F., Kandel E.R., Hawkins R.D. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. The Journal of Neuroscience 1999, 19(23):10250-10261.
148. Lundberg J.O., Weitzberg E., Gladwin M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature Reviews Drug Discovery 2008, 7(2):156-167.
149. Lyons C.R., Orloff G.J., Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. The Journal of Biological Chemistry 1992, 267(9):6370-6374.
150. Maggesissi R.S., Gardino P.F., Guimarães-Souza E.M., Paes-de-Carvalho R., Silva R.B., Calaza K.C. Modulation of GABA release by nitric oxide in the chick retina: Different effects of nitric oxide depending on the cell population. Vision Research 2009, 49(20):2494-2502.
151. Malenka R.C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994, 78(4):535-538.
152. Mander P., Borutaite V., Moncada S., Brown G.C. Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. Journal of Neuroscience Research 2005, 79(1-2):208-215.
153. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298(5600):1912-1934.
154. Martin A. Is tetralogy true? Lack of support for the "one-to-four rule". Molecular Biology and Evolution 2001, 18(1):89-93.
155. Mashimo H., Kjellin A., Goyal R.K. Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 2000, 119(3):766-773.
156. Masini E., Salvemini D., Pistelli A., Mannaioni P.F., Vane J.R. Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents and Actions 1991, 33(1-2):61-63.
157. Matsuo I., Hirooka Y., Hironaga K., Eshima K., Shigematsu H., Shihara M., et al. Glutamate release via NO production evoked by NMDA in the NTS enhances hypotension and bradycardia in vivo. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2001, 280(5):R1285-R1291.
158. McKim S.E., Gäbele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., et al. Inducible nitric oxide synthase is required in alcohol-induced liver injury: Studies with knockout mice. Gastroenterology 2003, 125(6):1834-1844.
159. McNaught K.S.P., Brown G.C. Nitric oxide causes glutamate release from brain synaptosomes. Journal of Neurochemistry 1998, 70(4):1541-1546.
160. Meffert M., Calakos N., Scheller R., Schulman H. Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 1996, 16(6):1229-1236.
161. 2+-independent synaptic vesicle release. Neuron 1994, 12(6):1235-1244.
162. 2+ and calmodulin/MAP kinase kinase/extracellular signal-regulated protein kinase signalling pathway in the mitogenic and antimitogenic effect of nitric oxide in glia- and neurone-derived cell lines. The European Journal of Neuroscience 2006, 23(7):1690-1700.
163. Mejía-García T., Paes-de-Carvalho R. Nitric oxide regulates cell survival in purified cultures of avian retinal neurons: Involvement of multiple transduction pathways. Journal of Neurochemistry 2007, 100(2):382-394.
164. Mejia-Garcia T.A., Portugal C.C., Encarnação T.G., Prado M.A., Paes-de-Carvalho R. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells. Cellular Signaling 2013, 25(12):2424-2439. pii: S0898-6568(13)00228-3.
165. Mendonça H.R., Araujo S.E., Gomes A.L., Sholl-Franco A., da Cunha Faria Melibeu A., Serfaty C.A., et al. Expression of GAP-43 during development and after monocular enucleation in the rat superior colliculus. Neuroscience Letters 2010, 477(1):23-27.
166. Mishra O.P., Ashraf Q.M., Delivoria-Papadopoulos M. NO-mediated activation of Src kinase during hypoxia in the cerebral cortex of newborn piglets. Neuroscience Letters 2009, 460(1):61-65.
167. 3H]aminobutyric acid release from striatal slices. Neuroscience Letters 1995, 190(3):195-198.
168. Monfort P., Munoz M.D., Kosenko E., Llansola M., Sanchez-Perez A., Cauli O., et al. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia. Neurochemistry International 2004, 45(6):895-901.
169. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994, 263(5149):973-977.
170. Mu Y., Poo M.M. Spike timing-dependent LTP/LTD mediates visual experience-dependent plasticity in a developing retinotectal system. Neuron 2006, 50(1):115-125.
171. Nakamura Y., Ohmaki M., Murakami K., Yoneda Y. Involvement of protein kinase C in glutamate release from cultured microglia. Brain Research 2003, 962(1):122-128.
172. Nakamura T., Tu S., Akhtar M.W., Sunico C.R., Okamoto S., Lipton S.A. Aberrant protein S-nitrosylation in neurodegenerative diseases. Neuron 2013, 78(4):596-614.
173. Nei K., Matsuyama S., Shuntoh H., Tanaka C. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Research 1996, 728(1):105-110.
174. Nikonenko I., Boda B., Steen S., Knott G., Welker E., Muller D. PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. The Journal of Cell Biology 2008, 183(6):1115-1127.
175. Nikonenko I., Jourdain P., Muller D. Presynaptic remodeling contributes to activity-dependent synaptogenesis. The Journal of Neuroscience 2003, 23(24):8498-8505.
176. Nishida K., Harrison D., Navas J., Fisher A., Dockery S., Uematsu M., et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. The Journal of Clinical Investigation 1992, 90(5):2092-2096.
177. Nott A., Watson P.M., Robinson J.D., Crepaldi L., Riccio A. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008, 455(7211):411-415.
178. Numajiri N., Takasawa K., Nishiya T., Tanaka H., Ohno K., Hayakawa W., et al. On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proceedings of the National Academy of Sciences of the United States of America 2011, 108(25):10349-10354.
179. O'dell T.J., Hawkins R.D., Kandel E.R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(24):11285-11289.
180. Ogasawara H., Doi T., Kawato M. Systems biology perspectives on cerebellar long-term depression. Neurosignals 2008, 16(4):300-317.
181. 3H] gamma-aminobutyric acid release is mediated by two distinct release mechanisms. Brain Research. Molecular Brain Research 1996, 36(1):137-144.
182. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna, Pant H.C., et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(20):11173-11178.
183. Oliveira-Silva P., Jurgilas P.B., Trindade P., Campello-Costa P., Perales J., Savino W., et al. Matrix metalloproteinase-9 is involved in the development and plasticity of retinotectal projections in rats. Neuroimmunomodulation 2007, 14(3-4):144-149.
184. Paes-de-Carvalho R., Maia G.A., Ferreira J.M. Adenosine regulates the survival of avian retinal neurons and photoreceptors in culture. Neurochemical Research 2003, 28(10):1583-1590.
185. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327(6122):524-526.
186. Pape H.C., Mager R. Nitric oxide controls oscillatory activity in thalamocortical neurons. Neuron 1992, 9(3):441-448.
187. Peltier J., O'Neill A., Schaffer D.V. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Developmental Neurobiology 2007, 67(10):1348-1361.
188. Penzes P., Cahill M.E., Jones K.A., VanLeeuwen J.E., Woolfrey K.M. Dendritic spine pathology in neuropsychiatric disorders. Nature Neuroscience 2011, 14(3):285-293.
189. Poglia L., Muller D., Nikonenko I. Ultrastructural modifications of spine and synapse morphology by SAP97. Hippocampus 2011, 21(9):990-998.
190. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Progress in Neurobiology 2001, 64(1):51-68.
191. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(10):4565-4571.
192. Qu J., Nakamura T., Cao G., Holland E.A., McKercher S.R., Lipton S.A. S-nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(34):14330-14335.
193. Radomski M., Palmer R., Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(13):5193-5197.
194. Ratnayaka A., Marra V., Bush D., Burden J.J., Branco T., Staras K. Recruitment of resting vesicles into recycling pools supports NMDA receptor-dependent synaptic potentiation in cultured hippocampal neurons. The Journal of Physiology 2012, 590(7):1585-1597.
195. 2+ release from cyclic ADP-ribose-sensitive stores. Journal of Neurophysiology 1999, 82(3):1569-1576.
196. Riccio A., Alvania R.S., Lonze B.E., Ramanan N., Kim T., Huang Y., et al. A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Molecular Cell 2006, 21(2):283-294.
197. Roskoski R. Src kinase regulation by phosphorylation and dephosphorylation. Biochemical and Biophysical Research Communications 2005, 331(1):1-14.
198. Rubinfeld H., Seger R. The ERK cascade: A prototype of MAPK signaling. Molecular Biotechnology 2005, 31(2):151-174.
199. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. The Journal of Clinical Investigation 1998, 101(4):731-736.
200. Samuels I.S., Saitta S.C., Landreth G.E. MAP'ing CNS development and cognition: An ERKsome process. Neuron 2009, 61(2):160-167.
201. Sanchez-Islas E., Leon-Olea M. Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain. Nitric Oxide 2004, 10(3):141-149.
202. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307(5712):1098-1101.
203. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chemical Research in Toxicology 2008, 21(1):172-188.
204. Scheetz A.J., Nairn A.C., Constantine-Paton M. NMDA receptor-mediated control of protein synthesis at developing synapses. Nature Neuroscience 2000, 3(3):211-216.
205. Schulz J.B., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D., et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. The Journal of Neuroscience 1995, 15(12):8419-8429.
206. Segieth J., Getting S.J., Biggs C.S., Whitton P.S. Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neuroscience Letters 1995, 200(2):101-104.
207. Segovia G., Mora F. Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Research Bulletin 1998, 45(3):275-279.
208. Selvakumar B., Huganir R.L., Snyder S.H. S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(38):16440-16445.
209. Sennlaub F., Courtois Y., Goureau O. Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. The Journal of Neuroscience 2002, 22(10):3987-3993.
210. Sequeira S.M., Ambrósio A.F., Malva J.O., Carvalho A.P., Carvalho C.M. Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. Nitric Oxide 1997, 1(4):315-329.
211. Sequeira S.M., Carvalho A.P., Carvalho C.M. Both protein kinase G dependent and independent mechanisms are involved in the modulation of glutamate release by nitric oxide in rat hippocampal nerve terminals. Neuroscience Letters 1999, 261(1):29-32.
212. Serfaty C.A., Campello-Costa P., Linden R. Rapid and long-term plasticity in the neonatal and adult retinotectal pathways following a retinal lesion. Brain Research. Bulletin 2005, 66(2):128-134.
213. Serfaty C.A., Linden R. Development of abnormal lamination and binocular segregation in the retinotectal pathways of the rat. Brain Research. Developmental Brain Research 1994, 82(1-2):35-44.
214. Serulle Y., Zhang S., Ninan I., Puzzo D., McCarthy M., Khatri L., et al. A GluR1-cGKII interaction regulates AMPA receptor trafficking. Neuron 2007, 56(4):670-688.
215. Sessa W.C., Harrison J.K., Barber C.M., Zeng D., Durieux M.E., D'Angelo D.D., et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. The Journal of Biological Chemistry 1992, 267(22):15274-15276.
216. Shahani N., Sawa A. Protein S-nitrosylation: Role for nitric oxide signaling in neuronal death. Biochimica et Biophysica Acta 2012, 1820(6):736-742.
217. Singewald N., Kaehler S.T., Hemeida R., Philippu A. Influence of excitatory amino acids on basal and sensory stimuli-induced release of 5-HT in the locus coeruleus. British Journal of Pharmacology 1998, 123(4):746-752.
218. Sistiaga A., Miras-Portugal T., Sánchez-Prieto J. Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway. European Journal of Pharmacology 1997, 321(2):247-257.
219. Smith J.C., Whitton P.S. Nitric oxide modulates N-methyl-d-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neuroscience Letters 2000, 291(1):5-8.
220. Socodato R.E.S., Magalhães C.R., Paes-de-Carvalho R. Glutamate and nitric oxide modulate ERK and CREB phosphorylation in the avian retina: Evidence for direct signaling from neurons to Müller glial cells. Journal of Neurochemistry 2009, 108(2):417-429.
221. Socodato R., Santiago F.N., Portugal C.C., Domingues A.F., Santiago A.R., Relvas J.B., et al. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors trigger neuronal nitric-oxide synthase activation to promote nerve cell death in an Src kinase-dependent fashion. The Journal of Biological Chemistry 2012, 287(46):38680-38694.
222. Sparacino-Watkins C.E., Lai Y.C., Gladwin M.T. Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics. Circulation 2012, 125(23):2824-2826.
223. Stamler J.S., Lamas S., Fang F.C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001, 106(6):675-683.
224. Stanton P.K., Winterer J., Bailey C.P., Kyrozis A., Raginov I., Laube G., et al. Long-term depression of presynaptic release from the readily releasable vesicle pool induced by NMDA receptor-dependent retrograde nitric oxide. The Journal of Neuroscience 2003, 23(13):5936-5944.
225. Strasser A., McCarron R.M., Ishii H., Stanimirovic D., Spatz M. l-Arginine induces dopamine release from the striatum in vivo. Neuroreport 1994, 5(17):2298-2300.
226. Straub V.A., Grant J., O'Shea M., Benjamin P.R. Modulation of serotonergic neurotransmission by nitric oxide. Journal of Neurophysiology 2007, 97(2):1088-1099.
227. Stuehr D.J., Gross S.S., Sakuma I., Levi R., Nathan C.F. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. The Journal of Experimental Medicine 1989, 169(3):1011-1020.
228. Trabace L., Kendrick K.M. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. Journal of Neurochemistry 2000, 75(4):1664-1674.
229. Trimm K.R., Rehder V. Nitric oxide acts as a slow-down and search signal in developing neurites. The European Journal of Neuroscience 2004, 19(4):809-818.
230. Tschetter W.W., Alam N.M., Yee C.W., Gorz M., Douglas R.M., Sagdullaev B., et al. Experience-enabled enhancement of adult visual cortex function. The Journal of Neuroscience 2013, 33(12):5362-5366.
231. Vesely D.L., Rovere L.E., Levey G.S. Activation of guanylate cyclase by streptozotocin and 1-methyl-1-nitrosourea. Cancer Research 1977, 37(1):28-31.
232. Wakatsuki H., Gomi H., Kudoh M., Kimura S., Takahashi K., Takeda M., et al. Layer-specific NO dependence of long-term potentiation and biased NO release in layer V in the rat auditory cortex. The Journal of Physiology 1998, 513(1):71-81.
233. Wang H.G., Lu F.M., Jin I., Udo H., Kandel E.R., de Vente J., et al. Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins. Neuron 2005, 45(3):389-403.
234. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. Journal of Neurochemistry 1997, 68(2):443-456.
235. Wang S., Teschemacher A.G., Paton J.F., Kasparov S. Mechanism of nitric oxide action on inhibitory GABAergic signaling within the nucleus tractus solitarii. The FASEB Journal 2006, 20(9):1537-1539.
236. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annual Review of Pharmacology and Toxicology 1981, 21:165-204.
237. Wedel B., Humbert P., Harteneck C., Foerster J., Malkewitz J., Böhme E., et al. Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(7):2592-2596.
238. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Progress in Neurobiology 2001, 64(4):365-391.
239. Williams C.V., Nordquist D., McLoon S.C. Correlation of nitric oxide synthase expression with changing patterns of axonal projections in the developing visual system. The Journal of Neuroscience 1994, 14(3-2):1746-1755.
240. Willmott N.J., Wong K., Strong A.J. A fundamental role for the nitric oxide-G-kinase signaling pathway in mediating intercellular Ca(2+) waves in glia. The Journal of Neuroscience 2000, 20(5):1767-1779.
241. Won H., Mah W., Kim E. Autism spectrum disorder causes, mechanisms, and treatments: Focus on neuronal synapses. Frontiers in Molecular Neuroscience 2013, 6:1-19.
242. Wu H.H., Williams C.V., McLoon S.C. Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 1994, 265(5178):1593-1596.
243. Xie Q.-W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256(5054):225-228.
244. Xie Z., Sanada K., Samuels B.A., Shih H., Tsai L.H. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 2003, 114(4):469-482.
245. Yamasaki K., Edington H., McClosky C., Tzeng E., Lizonova A., Kovesdi I., et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. The Journal of Clinical Investigation 1998, 101(5):967-971.
246. Yang Q., Chen S.R., Li D.P., Pan H.L. Kv1.1/1.2 channels are downstream effectors of nitric oxide on synaptic GABA release to preautonomic neurons in the paraventricular nucleus. Neuroscience 2007, 149(2):315-327.
247. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. Journal of Cerebral Blood Flow and Metabolism 1994, 14(6):924-929.
248. Yoshihara Y., De Roo M., Muller D. Dendritic spine formation and stabilization. Current Opinion in Neurobiology 2009, 19(2):146-153.
249. Yu D., Eldred W.D. Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina. The Journal of Comparative Neurology 2005, 483(3):278-291.
250. Zhang C., Granstrom L., Wong-Riley M.T. Deafferentation leads to a down-regulation of nitric oxide synthase in the rat visual system. Neuroscience Letters 1996, 211(1):61-64.
251. Zhang P., Yu P.C., Tsang A.H., Chen Y., Fu A.K., Fu W.Y., et al. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development. The Journal of Neuroscience 2010, 30(43):14366-14370.
252. Zhou P., Qian L., Iadecola C. Nitric oxide inhibits caspase activation and apoptotic morphology but does not rescue neuronal death. Journal of Cerebral Blood Flow and Metabolism 2005, 25(3):348-357.
253. Zhu X.Z., Luo L.G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. Journal of Neurochemistry 1992, 59(3):932-935.